Aura Biosciences Inc
NASDAQ:AURA
Aura Biosciences Inc
NASDAQ:AURA
Price:
6.53
USD
-0.31%
Market Closed
Market Cap:
$414.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Aura Biosciences Inc
NASDAQ:AURA
|
US |
|
A
|
Alco Holdings Ltd
HKEX:328
|
HK |
|
Ashmore Group PLC
LSE:ASHM
|
UK |
|
Capital Financial Indonesia Tbk PT
IDX:CASA
|
ID |
|
K
|
Kiwibox.com Inc
OTC:KIWB
|
US |
|
Tasman Resources Ltd
ASX:TAS
|
AU |
|
Amadeus Fire AG
XETRA:AAD
|
DE |
|
Corcept Therapeutics Inc
NASDAQ:CORT
|
US |
Relative Value
The Relative Value of one
AURA
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 6.53 USD,
Aura Biosciences Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AURA Relative Value
HIDDEN
Multiples Across Competitors
AURA Competitors Multiples
Aura Biosciences Inc Competitors
Aura Biosciences Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Aura Biosciences Inc
NASDAQ:AURA
|
411.3m USD | 0 | -3.9 | -2.2 | -2.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.3B USD | 5.9 | 86.5 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.4B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.6B USD | 9.5 | 29 | 21.8 | 22.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.9B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.4B AUD | 3.1 | 34.3 | 11.4 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.6B USD | 10.9 | 129.6 | 72.5 | 80.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
